» Articles » PMID: 14656913

Randomized Comparison Between Stenting and Off-pump Bypass Surgery in Patients Referred for Angioplasty

Overview
Journal Circulation
Date 2003 Dec 6
PMID 14656913
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Stenting improves cardiac outcome in comparison with balloon angioplasty. Compared with conventional surgery, off-pump bypass surgery on the beating heart without cardiopulmonary bypass may reduce morbidity, hospital stay, and costs. The purpose, therefore, was to compare cardiac outcome, quality of life, and cost-effectiveness 1 year after stenting and after off-pump surgery.

Methods And Results: Patients referred for angioplasty (n=280) were randomly assigned to stenting (n=138) or off-pump bypass surgery. At 1 year, survival free from stroke, myocardial infarction, and repeat revascularization was 85.5% after stenting and 91.5% after off-pump surgery (relative risk, 0.93; 95% CI, 0.86 to 1.02). Freedom from angina was 78.3% after stenting and 87.0% after off-pump surgery (P=0.06). Quality-adjusted lifetime was 0.82 year after stenting and 0.79 year after off-pump surgery (P=0.09). Hospital stay after the initial procedure was 1.43 and 5.77 days, respectively (P<0.01). Stenting reduced overall costs by 2933 dollars (26.2%) per patient (8276 dollars versus 11 209 dollars; P<0.01). Stenting was more cost-effective in 95% of the bootstrap estimates.

Conclusions: At 1 year, stenting was more cost-effective than off-pump surgery while maintaining comparable cardiac outcome and quality of life. Stenting rather than off-pump surgery, therefore, can be recommended as a first-choice revascularization strategy in selected patients.

Citing Articles

Difference in spontaneous myocardial infarction and mortality in percutaneous versus surgical revascularization trials: A systematic review and meta-analysis.

Gaudino M, Di Franco A, Spadaccio C, Rahouma M, Robinson N, Demetres M J Thorac Cardiovasc Surg. 2021; 165(2):662-669.e14.

PMID: 34045061 PMC: 8802340. DOI: 10.1016/j.jtcvs.2021.04.062.


Neurological outcome after minimally invasive coronary artery bypass surgery (NOMICS): An observational prospective cohort study.

Stessel B, Nijs K, Pelckmans C, Vandenbrande J, Ory J, Yilmaz A PLoS One. 2020; 15(12):e0242519.

PMID: 33362277 PMC: 7757846. DOI: 10.1371/journal.pone.0242519.


Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis.

Gaudino M, Hameed I, Farkouh M, Rahouma M, Naik A, Robinson N JAMA Intern Med. 2020; 180(12):1638-1646.

PMID: 33044497 PMC: 7551235. DOI: 10.1001/jamainternmed.2020.4748.


Assessment of the Quality of Life in Patients before and after Coronary Artery Bypass Grafting (CABG): A Prospective Study.

Pacaric S, Turk T, Eric I, Orkic Z, Eric A, Milostic-Srb A Int J Environ Res Public Health. 2020; 17(4).

PMID: 32098322 PMC: 7068373. DOI: 10.3390/ijerph17041417.


Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands.

Roze S, Smith-Palmer J, de Portu S, Delbaere A, de Brouwer B, de Valk H Clinicoecon Outcomes Res. 2019; 11:73-82.

PMID: 30679914 PMC: 6336135. DOI: 10.2147/CEOR.S186298.